These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 11349627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
    Gurm HS, Bhatt DL.
    Am Heart J; 2005 Jan; 149(1 Suppl):S43-53. PubMed ID: 15644793
    [No Abstract] [Full Text] [Related]

  • 3. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group.
    Lancet; 2002 Jan 26; 359(9303):294-302. PubMed ID: 11830196
    [Abstract] [Full Text] [Related]

  • 4. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb 26; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 5. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M, Gustafsson D, Deinum J.
    Thromb Haemost; 1997 Oct 26; 78(4):1286-92. PubMed ID: 9364999
    [Abstract] [Full Text] [Related]

  • 6. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT, Paul W, Emerson M, Cicala C, Page CP.
    Eur J Pharmacol; 1994 Oct 24; 264(2):183-90. PubMed ID: 7851481
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD.
    Clin Ther; 2002 Jan 24; 24(1):38-58. PubMed ID: 11833835
    [Abstract] [Full Text] [Related]

  • 10. Advances in antithrombotic therapy: novel agents.
    Turpie AG, Weitz JI, Hirsh J.
    Thromb Haemost; 1995 Jul 24; 74(1):565-71. PubMed ID: 8578525
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition.
    Reginelli JP, Chew D.
    J Interv Cardiol; 2002 Apr 24; 15(2):141-6. PubMed ID: 12063809
    [No Abstract] [Full Text] [Related]

  • 13. Modulating platelet function with selective thrombin inhibitors.
    Verstraete M.
    Haemostasis; 1996 Oct 24; 26 Suppl 4():70-7. PubMed ID: 8979113
    [Abstract] [Full Text] [Related]

  • 14. [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors].
    Puccio D, Montalto S, Valerio MC, Ventimiglia A, Caronia A, Novo S.
    G Ital Cardiol (Rome); 2006 Nov 24; 7(11):739-46. PubMed ID: 17216915
    [Abstract] [Full Text] [Related]

  • 15. Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance.
    Verstraete M.
    Thromb Haemost; 1997 Jul 24; 78(1):357-63. PubMed ID: 9198179
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
    Fuchs J, Cannon CP.
    Circulation; 1995 Aug 15; 92(4):727-33. PubMed ID: 7641350
    [Abstract] [Full Text] [Related]

  • 20. Clinician update: direct thrombin inhibitors in acute coronary syndromes.
    Wykrzykowska JJ, Kathiresan S, Jang IK.
    J Thromb Thrombolysis; 2003 Feb 15; 15(1):47-57. PubMed ID: 14574076
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.